SRTS (Sensus Healthcare, Inc) Stock Analysis - Analyst Ratings

Sensus Healthcare, Inc (SRTS) is a publicly traded Healthcare sector company. As of May 21, 2026, SRTS trades at $3.07 with a market cap of $57.12M and a P/E ratio of -6.94. SRTS moved -2.84% today. Year to date, SRTS is -25.39%; over the trailing twelve months it is -30.83%. Its 52-week range spans $2.82 to $9.33. Analyst consensus is strong buy with an average price target of $5.67. Rallies surfaces SRTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SRTS?

3 analysts cover SRTS: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $5.67.

SRTS Key Metrics

Key financial metrics for SRTS
MetricValue
Price$3.07
Market Cap$57.12M
P/E Ratio-6.94
EPS$-0.47
Dividend Yield0.00%
52-Week High$9.33
52-Week Low$2.82
Volume128
Avg Volume0
Revenue (TTM)$22.53M
Net Income$-7.77M
Gross Margin37.74%

SRTS Analyst Consensus

3 analysts cover SRTS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.67.

Latest SRTS News

Recent SRTS Insider Trades

  • Sachetta Eric bought 1.50K (~$5.00K) on May 12, 2026.
  • Sachetta Eric bought 2.00K (~$7.62K) on Feb 24, 2026.
  • Sachetta Eric bought 7.00K (~$27.51K) on Nov 21, 2025.

Common questions about SRTS

What do analysts rate SRTS?
3 analysts cover SRTS: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $5.67.
Does Rallies show SRTS price targets?
Yes. Rallies tracks SRTS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SRTS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SRTS. It does not provide personalized investment advice.
SRTS

SRTS